Startup Codon Devices is creating entirely synthetic cells, proteins, and microorganisms. Someday they could be used to produce drugs or clean up pollution.
Energy investors get great stock performances--plus cash!
Technology Review’s annual look at research trends in corporations is led this year by pharmaceutical and biotech companies.
InPhase Technologies hopes to bring its novel 3-D storage product to market by next year--and revolutionize how you store your data.
U.S. stem cell researchers fight with uncertain financing and esoteric restrictions. Can the science survive under these conditions?
Meshes will be the mechanism by which machine intelligence becomes like electricity: invisible and ubiquitous.
MIT photographer Felice Frankel has been teaching the importance of images to an unlikely crowd: scientists.
Osiris Therapeutics, Miasole, PicoChip, and more
New hopes for combating the disease
Apple sees greater risk in staying with IBM's chips than in aligning itself with Intel.